Dr. Waples is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Cci Dr Nw
Huntsville, AL 35805Phone+1 256-705-4224Fax+1 256-705-4135
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 1995 - 1998- University of FloridaResidency, Internal Medicine, 1992 - 1995
- University of Florida College of MedicineClass of 1992
Certifications & Licensure
AL State Medical License 1998 - 2024
TN State Medical License 2013 - 2016
FL State Medical License 1994 - 2000- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma Start of enrollment: 2003 Oct 01
- Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) Start of enrollment: 2004 Feb 01
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 19 citationsManagement of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant.Marc Zumberg, John M. Waples, K.J. Kao, Richard Lottenberg
American Journal of Hematology. 2000-05-01 - 7 citationsA phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.Bradley J. G. Larson, John M. Waples, Annette Pusateri, Nancy P. Mendenhall, James W. Lynch
American Journal of Clinical Oncology. 2005-04-01
Press Mentions
OneOncology Partners With Huntsville's Clearview Cancer InstituteJanuary 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
